{"hands_on_practices": [{"introduction": "The cyclooxygenase enzymes, COX-1 and COX-2, are central to prostanoid synthesis and are the primary targets of nonsteroidal anti-inflammatory drugs (NSAIDs). To understand their distinct physiological roles and the selectivity of different drugs, it is essential to appreciate their kinetic properties. This exercise allows you to apply the foundational Michaelis-Menten model to quantitatively compare the catalytic activities of COX-1 and COX-2 under a hypothetical inflammatory condition, offering insight into their different contributions to homeostasis and inflammation. [@problem_id:4328611]", "problem": "Cyclooxygenase enzymes convert arachidonic acid to prostaglandin H2 (PGH2) via a cyclooxygenase reaction followed by a peroxidase reaction. Assume that under an acute inflammatory stimulus in a vascular tissue, free arachidonic acid is maintained at a constant concentration by phospholipase A2 activity and that initial-rate, steady-state Michaelis–Menten kinetics apply to the overall conversion to PGH2 for each isoform separately. Ignore product inhibition, substrate depletion, and any differences in peroxidase coupling efficiency between isoforms. Let cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) each follow single-substrate enzyme kinetics characterized by a catalytic turnover number $k_{\\text{cat}}$, a Michaelis constant $K_m$, and a total active enzyme concentration $[E]_T$.\n\nFor COX-1, the parameters are $k_{\\text{cat},1} = 7~\\mathrm{s}^{-1}$, $K_{m,1} = 4~\\mu\\mathrm{M}$, and $[E_1]_T = 60~\\mathrm{nM}$. For COX-2, the parameters are $k_{\\text{cat},2} = 14~\\mathrm{s}^{-1}$, $K_{m,2} = 8~\\mu\\mathrm{M}$, and $[E_2]_T = 40~\\mathrm{nM}$. The arachidonic acid substrate concentration is $[S] = 10~\\mu\\mathrm{M}$.\n\nUsing only the steady-state Michaelis–Menten framework and the definitions of $k_{\\text{cat}}$, $K_m$, and $[E]_T$, derive the expression for the initial velocity of PGH2 formation for each isoform in terms of these parameters and $[S]$, and from these expressions compute the ratio\n$$R = \\frac{v_{\\text{COX-2}}}{v_{\\text{COX-1}}}.$$\nReport $R$ as a pure number (unitless) and round your answer to four significant figures.", "solution": "The initial velocity, $v$, of an enzyme-catalyzed reaction under steady-state Michaelis-Menten kinetics is given by the equation:\n$$v = \\frac{V_{\\text{max}} [S]}{K_m + [S]}$$\nwhere $V_{\\text{max}}$ is the maximum reaction velocity, $K_m$ is the Michaelis constant, and $[S]$ is the substrate concentration.\n\nThe maximum velocity, $V_{\\text{max}}$, is defined as the product of the catalytic turnover number, $k_{\\text{cat}}$, and the total enzyme concentration, $[E]_T$:\n$$V_{\\text{max}} = k_{\\text{cat}} [E]_T$$\n\nBy substituting the expression for $V_{\\text{max}}$ into the Michaelis-Menten equation, we obtain the initial velocity in terms of the parameters provided in the problem statement:\n$$v = \\frac{k_{\\text{cat}} [E]_T [S]}{K_m + [S]}$$\n\nWe apply this general expression to each cyclooxygenase isoform, COX-1 and COX-2, using their respective kinetic parameters.\n\nFor COX-1, the initial velocity of PGH2 formation, $v_{\\text{COX-1}}$, is:\n$$v_{\\text{COX-1}} = \\frac{k_{\\text{cat},1} [E_1]_T [S]}{K_{m,1} + [S]}$$\n\nFor COX-2, the initial velocity of PGH2 formation, $v_{\\text{COX-2}}$, is:\n$$v_{\\text{COX-2}} = \\frac{k_{\\text{cat},2} [E_2]_T [S]}{K_{m,2} + [S]}$$\n\nThe problem requires the computation of the ratio $R = \\frac{v_{\\text{COX-2}}}{v_{\\text{COX-1}}}$. We construct this ratio using the expressions derived above:\n$$R = \\frac{v_{\\text{COX-2}}}{v_{\\text{COX-1}}} = \\frac{\\left( \\frac{k_{\\text{cat},2} [E_2]_T [S]}{K_{m,2} + [S]} \\right)}{\\left( \\frac{k_{\\text{cat},1} [E_1]_T [S]}{K_{m,1} + [S]} \\right)}$$\n\nWe can simplify this compound fraction. The substrate concentration $[S]$ term in the numerators cancels out:\n$$R = \\frac{k_{\\text{cat},2} [E_2]_T}{k_{\\text{cat},1} [E_1]_T} \\cdot \\frac{K_{m,1} + [S]}{K_{m,2} + [S]}$$\n\nNow, we substitute the given numerical values into this expression. First, we must ensure all concentration units are consistent. We will convert all concentrations to micromolar ($\\mu\\mathrm{M}$).\nThe given parameters are:\nFor COX-1:\n$k_{\\text{cat},1} = 7~\\mathrm{s}^{-1}$\n$K_{m,1} = 4~\\mu\\mathrm{M}$\n$[E_1]_T = 60~\\mathrm{nM} = 60 \\times 10^{-3}~\\mu\\mathrm{M} = 0.060~\\mu\\mathrm{M}$\n\nFor COX-2:\n$k_{\\text{cat},2} = 14~\\mathrm{s}^{-1}$\n$K_{m,2} = 8~\\mu\\mathrm{M}$\n$[E_2]_T = 40~\\mathrm{nM} = 40 \\times 10^{-3}~\\mu\\mathrm{M} = 0.040~\\mu\\mathrm{M}$\n\nSubstrate concentration:\n$[S] = 10~\\mu\\mathrm{M}$\n\nSubstituting these values into the expression for $R$:\n$$R = \\frac{(14~\\mathrm{s}^{-1}) (0.040~\\mu\\mathrm{M})}{(7~\\mathrm{s}^{-1}) (0.060~\\mu\\mathrm{M})} \\cdot \\frac{(4~\\mu\\mathrm{M}) + (10~\\mu\\mathrm{M})}{(8~\\mu\\mathrm{M}) + (10~\\mu\\mathrm{M})}$$\nThe units for $k_{\\text{cat}}$ ($\\mathrm{s}^{-1}$) and concentration ($\\mu\\mathrm{M}$) cancel, yielding a dimensionless ratio as expected.\n$$R = \\frac{14 \\times 0.040}{7 \\times 0.060} \\cdot \\frac{4 + 10}{8 + 10}$$\n$$R = \\frac{0.56}{0.42} \\cdot \\frac{14}{18}$$\nWe can simplify the fractions:\n$$\\frac{0.56}{0.42} = \\frac{56}{42} = \\frac{4}{3}$$\n$$\\frac{14}{18} = \\frac{7}{9}$$\nNow, we multiply the simplified fractions:\n$$R = \\frac{4}{3} \\cdot \\frac{7}{9} = \\frac{28}{27}$$\nTo provide the numerical answer, we compute the value of the fraction and round to four significant figures as required.\n$$R = \\frac{28}{27} \\approx 1.0370370...$$\nRounding to four significant figures, we get:\n$$R \\approx 1.037$$", "answer": "$$\\boxed{1.037}$$", "id": "4328611"}, {"introduction": "Arachidonic acid sits at a crucial metabolic fork, serving as a precursor for both prostanoids (via COX enzymes) and leukotrienes (via 5-LOX). This creates competition for the common substrate, leading to a phenomenon known as metabolic shunting, a critical concept in pharmacology. This practice models a classic experimental scenario—the genetic knockout of a key protein in one pathway—to let you calculate how inhibiting the leukotriene pathway quantitatively affects the flow of substrate through the prostanoid pathway. [@problem_id:4328588]", "problem": "In an inflamed macrophage, arachidonic acid is liberated from membrane phospholipids at a constant rate by phospholipase activity during a brief early phase of stimulation. Consider a simplified steady-state partitioning of arachidonic acid into two competing enzymatic fates: cyclooxygenase (COX) for prostanoid synthesis and 5-lipoxygenase (5-LOX) for leukotriene synthesis. The 5-lipoxygenase-activating protein (FLAP) facilitates substrate presentation to 5-LOX. In a FLAP knockout, substrate presentation to 5-LOX is constrained, reducing leukotriene flux.\n\nAssume the following foundational biochemistry:\n- Under the given stimulus, the cytosolic free arachidonic acid concentration remains low enough that both COX and 5-LOX operate in the linear, substrate-limited regime of Michaelis–Menten kinetics, so that each pathway’s instantaneous flux is proportional to the arachidonic acid concentration. For an enzyme with maximal velocity $V_{\\max}$ and Michaelis constant $K_{m}$, the effective first-order rate constant is $k = V_{\\max}/K_{m}$ when $[S] \\ll K_{m}$.\n- Arachidonic acid is supplied at a constant rate $R$ and consumed only by COX and 5-LOX, reaching a steady state where supply equals total consumption.\n- In the wild type, COX has $V_{\\max,\\mathrm{COX}} = 2.0$ $\\mathrm{\\mu M\\,s^{-1}}$ and $K_{m,\\mathrm{COX}} = 10.0$ $\\mathrm{\\mu M}$, and 5-LOX has $V_{\\max,\\mathrm{5LOX}} = 3.0$ $\\mathrm{\\mu M\\,s^{-1}}$ and $K_{m,\\mathrm{5LOX}} = 5.0$ $\\mathrm{\\mu M}$.\n- In the FLAP knockout, constrained substrate presentation to 5-LOX reduces its effective first-order rate constant by a multiplicative factor $\\beta = 0.10$ relative to wild type, while COX parameters are unchanged.\n\nStarting only from mass balance at steady state and the linearized Michaelis–Menten relationship in the substrate-limited regime, derive and compute the fold-change in the steady-state COX-driven prostanoid flux in the FLAP knockout relative to wild type. Express your final answer as a pure number (dimensionless), rounded to four significant figures.", "solution": "The problem asks for the fold-change in the steady-state flux through the cyclooxygenase (COX) pathway when the 5-lipoxygenase (5-LOX) pathway is partially inhibited. We will approach this using a steady-state mass balance for the substrate, arachidonic acid ($AA$).\n\nFirst, we define the kinetic parameters based on the information provided. The problem states that both enzymes, COX and 5-LOX, operate in the linear, substrate-limited regime ($[AA] \\ll K_m$). In this regime, the Michaelis–Menten rate law, $v = \\frac{V_{\\max}[S]}{K_m + [S]}$, simplifies to a first-order rate law:\n$$v \\approx \\left(\\frac{V_{\\max}}{K_m}\\right)[S] = k[S]$$\nwhere $k = V_{\\max}/K_m$ is the effective first-order rate constant.\n\nLet's calculate the rate constants for the wild-type (WT) condition.\nFor the COX pathway:\n$V_{\\max,\\mathrm{COX}} = 2.0 \\ \\mathrm{\\mu M\\,s^{-1}}$\n$K_{m,\\mathrm{COX}} = 10.0 \\ \\mathrm{\\mu M}$\nThe first-order rate constant for COX is:\n$$k_{\\mathrm{COX}} = \\frac{V_{\\max,\\mathrm{COX}}}{K_{m,\\mathrm{COX}}} = \\frac{2.0 \\ \\mathrm{\\mu M\\,s^{-1}}}{10.0 \\ \\mathrm{\\mu M}} = 0.20 \\ \\mathrm{s^{-1}}$$\n\nFor the 5-LOX pathway in the wild type:\n$V_{\\max,\\mathrm{5LOX}} = 3.0 \\ \\mathrm{\\mu M\\,s^{-1}}$\n$K_{m,\\mathrm{5LOX}} = 5.0 \\ \\mathrm{\\mu M}$\nThe first-order rate constant for 5-LOX is:\n$$k_{\\mathrm{5LOX,WT}} = \\frac{V_{\\max,\\mathrm{5LOX}}}{K_{m,\\mathrm{5LOX}}} = \\frac{3.0 \\ \\mathrm{\\mu M\\,s^{-1}}}{5.0 \\ \\mathrm{\\mu M}} = 0.60 \\ \\mathrm{s^{-1}}$$\nFor brevity, we will denote $k_{\\mathrm{5LOX,WT}}$ as $k_{\\mathrm{5LOX}}$.\n\nArachidonic acid is supplied at a constant rate $R$ and consumed by the two pathways. At steady state, the rate of supply equals the rate of consumption. Let $[AA]$ be the steady-state concentration of arachidonic acid.\n$$R = v_{\\mathrm{total}} = v_{\\mathrm{COX}} + v_{\\mathrm{5LOX}}$$\nUsing the first-order rate laws:\n$$R = k_{\\mathrm{COX}}[AA] + k_{\\mathrm{5LOX}}[AA] = (k_{\\mathrm{COX}} + k_{\\mathrm{5LOX, total}})[AA]$$\nwhere $k_{\\mathrm{5LOX, total}}$ represents the effective 5-LOX rate constant for a given condition (WT or knockout).\n\nWe can solve for the steady-state arachidonic acid concentration:\n$$[AA] = \\frac{R}{k_{\\mathrm{COX}} + k_{\\mathrm{5LOX, total}}}$$\n\nNow, we analyze the two specific cases: Wild Type (WT) and FLAP Knockout (KO).\n\nCase 1: Wild Type (WT)\nIn the WT condition, the 5-LOX pathway is fully active.\n$k_{\\mathrm{COX,WT}} = k_{\\mathrm{COX}}$\n$k_{\\mathrm{5LOX,WT}} = k_{\\mathrm{5LOX}}$\nThe steady-state concentration of arachidonic acid in the WT, $[AA]_{\\mathrm{WT}}$, is:\n$$[AA]_{\\mathrm{WT}} = \\frac{R}{k_{\\mathrm{COX}} + k_{\\mathrm{5LOX}}}$$\nThe steady-state flux through the COX pathway in the WT, $v_{\\mathrm{COX,WT}}$, is:\n$$v_{\\mathrm{COX,WT}} = k_{\\mathrm{COX}}[AA]_{\\mathrm{WT}} = k_{\\mathrm{COX}}\\left(\\frac{R}{k_{\\mathrm{COX}} + k_{\\mathrm{5LOX}}}\\right)$$\n\nCase 2: FLAP Knockout (KO)\nIn the KO condition, the COX pathway is unaffected, so $k_{\\mathrm{COX,KO}} = k_{\\mathrm{COX}}$. However, the 5-LOX pathway is impaired. The problem states its effective first-order rate constant is reduced by a multiplicative factor $\\beta = 0.10$.\n$$k_{\\mathrm{5LOX,KO}} = \\beta \\cdot k_{\\mathrm{5LOX}}$$\nThe steady-state concentration of arachidonic acid in the KO, $[AA]_{\\mathrm{KO}}$, is:\n$$[AA]_{\\mathrm{KO}} = \\frac{R}{k_{\\mathrm{COX}} + k_{\\mathrm{5LOX,KO}}} = \\frac{R}{k_{\\mathrm{COX}} + \\beta k_{\\mathrm{5LOX}}}$$\nThe steady-state flux through the COX pathway in the KO, $v_{\\mathrm{COX,KO}}$, is:\n$$v_{\\mathrm{COX,KO}} = k_{\\mathrm{COX}}[AA]_{\\mathrm{KO}} = k_{\\mathrm{COX}}\\left(\\frac{R}{k_{\\mathrm{COX}} + \\beta k_{\\mathrm{5LOX}}}\\right)$$\n\nWe are asked to find the fold-change in the COX-driven flux in the KO relative to the WT. This is the ratio $\\frac{v_{\\mathrm{COX,KO}}}{v_{\\mathrm{COX,WT}}}$.\n$$\\text{Fold-change} = \\frac{v_{\\mathrm{COX,KO}}}{v_{\\mathrm{COX,WT}}} = \\frac{k_{\\mathrm{COX}}\\left(\\frac{R}{k_{\\mathrm{COX}} + \\beta k_{\\mathrm{5LOX}}}\\right)}{k_{\\mathrm{COX}}\\left(\\frac{R}{k_{\\mathrm{COX}} + k_{\\mathrm{5LOX}}}\\right)}$$\nThe terms $k_{\\mathrm{COX}}$ and $R$ cancel, yielding the symbolic expression for the fold-change:\n$$\\text{Fold-change} = \\frac{k_{\\mathrm{COX}} + k_{\\mathrm{5LOX}}}{k_{\\mathrm{COX}} + \\beta k_{\\mathrm{5LOX}}}$$\n\nNow, we substitute the numerical values we calculated:\n$k_{\\mathrm{COX}} = 0.20 \\ \\mathrm{s^{-1}}$\n$k_{\\mathrm{5LOX}} = 0.60 \\ \\mathrm{s^{-1}}$\n$\\beta = 0.10$\n\n$$\\text{Fold-change} = \\frac{0.20 \\ \\mathrm{s^{-1}} + 0.60 \\ \\mathrm{s^{-1}}}{0.20 \\ \\mathrm{s^{-1}} + (0.10)(0.60 \\ \\mathrm{s^{-1}})} = \\frac{0.80}{0.20 + 0.060} = \\frac{0.80}{0.26}$$\nPerforming the division:\n$$\\text{Fold-change} \\approx 3.076923...$$\nThe problem requires the answer to be rounded to four significant figures.\n$$\\text{Fold-change} \\approx 3.077$$\nThe inhibition of the competing 5-LOX pathway leads to an accumulation of the substrate arachidonic acid, which in turn shunts more substrate through the COX pathway, increasing its flux by a factor of approximately $3.077$.", "answer": "$$\\boxed{3.077}$$", "id": "4328588"}, {"introduction": "The biochemical actions of eicosanoids have profound consequences for organ physiology, acting as powerful local hormones. A prime example is the role of prostacyclin ($PGI_2$) in regulating blood flow and filtration in the kidney. This exercise bridges the gap between molecular biochemistry and systemic function by having you model the hemodynamics of the glomerulus, allowing you to calculate the direct impact of inhibiting $PGI_2$-mediated vasodilation on the glomerular filtration rate (GFR) and providing a tangible link between a single metabolite and a vital physiological parameter. [@problem_id:4328593]", "problem": "Arachidonic acid metabolites such as prostacyclin ($PGI_2$) maintain renal afferent arteriolar dilation under physiological stress. Consider a steady-state, lumped hemodynamic model of a single kidney in which the glomerular filtration rate (GFR) is determined by the ultrafiltration coefficient $K_f$ and the net filtration pressure via the relation $GFR = K_f\\,(P_{GC} - P_{BS} - \\pi_{GC})$, where $P_{GC}$ is the glomerular capillary hydrostatic pressure, $P_{BS}$ is the hydrostatic pressure in Bowman’s space, and $\\pi_{GC}$ is the average glomerular capillary oncotic pressure. Assume viscous flow in series vascular segments so that volumetric flow $Q$ satisfies $Q = (P_A - P_V)/(R_A + R_E)$, with $P_A$ the renal arterial pressure, $P_V$ the renal venous pressure, and $R_A$, $R_E$ the afferent and efferent arteriolar resistances, respectively. The pressure drop across the afferent arteriole gives $P_{GC} = P_A - Q\\,R_A$.\n\nBaseline values are: $P_A = 100$ mmHg, $P_V = 10$ mmHg, $R_A = \\frac{2}{25}$ mmHg·min/ml, $R_E = \\frac{7}{100}$ mmHg·min/ml, $P_{BS} = 15$ mmHg, and $\\pi_{GC} = 25$ mmHg. Baseline GFR is $125$ ml/min. Treat $K_f$ as a constant property of the filtration barrier that you must infer from the baseline.\n\nAfter pharmacologic inhibition of prostacyclin ($PGI_2$)-mediated afferent dilation, the afferent arteriolar resistance increases by a factor of $1.3$ while $R_E$, $P_A$, $P_V$, $P_{BS}$, and $\\pi_{GC}$ remain unchanged for the purpose of isolating the hemodynamic contribution of $P_{GC}$. Neglect any feedback changes in $K_f$, $P_{BS}$, or $\\pi_{GC}$.\n\nUsing only the relations stated above, compute the change in glomerular filtration rate attributable solely to the altered $P_{GC}$ (that is, holding $K_f$, $P_{BS}$, and $\\pi_{GC}$ at their baseline values while updating $P_{GC}$ via the new $R_A$). Express your final answer in ml/min and round to four significant figures.", "solution": "The solution proceeds in three main parts. First, we characterize the baseline state and calculate the ultrafiltration coefficient, $K_f$. Second, we calculate the new hemodynamic state after the increase in afferent resistance. Finally, we compute the change in GFR. All units are consistent (mmHg, ml, min), so they can be omitted from intermediate calculations for brevity.\n\n**Part 1: Baseline State and Calculation of $K_f$**\n\nWe are given the baseline values for pressures and resistances.\n$P_A = 100$\n$P_V = 10$\n$R_A = \\frac{2}{25} = 0.08$\n$R_E = \\frac{7}{100} = 0.07$\n\nFirst, we calculate the baseline renal plasma flow, $Q_{base}$, using the series resistance formula:\n$$Q_{base} = \\frac{P_A - P_V}{R_A + R_E} = \\frac{100 - 10}{0.08 + 0.07} = \\frac{90}{0.15} = 600 \\text{ ml/min}$$\n\nNext, we calculate the baseline glomerular capillary hydrostatic pressure, $P_{GC, base}$:\n$$P_{GC, base} = P_A - Q_{base} \\cdot R_A = 100 - (600 \\cdot 0.08) = 100 - 48 = 52 \\text{ mmHg}$$\n\nNow, we can calculate the net filtration pressure at baseline, $NFP_{base}$, using the given values for $P_{BS}$ and $\\pi_{GC}$:\n$P_{BS} = 15$\n$\\pi_{GC} = 25$\n$$NFP_{base} = P_{GC, base} - P_{BS} - \\pi_{GC} = 52 - 15 - 25 = 12 \\text{ mmHg}$$\n\nThe problem states that the baseline GFR is $125$ ml/min. We use this to determine the ultrafiltration coefficient, $K_f$:\n$$GFR_{base} = K_f \\cdot NFP_{base}$$\n$$125 = K_f \\cdot 12$$\n$$K_f = \\frac{125}{12} \\frac{\\text{ml/min}}{\\text{mmHg}}$$\nWe will keep $K_f$ in this exact fractional form to maintain precision.\n\n**Part 2: Post-Inhibition State**\n\nAfter inhibition of prostacyclin, the afferent arteriolar resistance, $R_A$, increases by a factor of $1.3$. The new resistance, $R_A'$, is:\n$$R_A' = 1.3 \\cdot R_A = 1.3 \\cdot 0.08 = 0.104 \\frac{\\text{mmHg}\\cdot\\text{min}}{\\text{ml}}$$\n\nAll other relevant parameters ($P_A$, $P_V$, $R_E$, $P_{BS}$, $\\pi_{GC}$, $K_f$) are held constant. We now calculate the new renal plasma flow, $Q'$:\n$$Q' = \\frac{P_A - P_V}{R_A' + R_E} = \\frac{100 - 10}{0.104 + 0.07} = \\frac{90}{0.174} = \\frac{90000}{174} = \\frac{15000}{29} \\text{ ml/min}$$\n\nNext, we calculate the new glomerular capillary hydrostatic pressure, $P_{GC}'$:\n$$P_{GC}' = P_A - Q' \\cdot R_A' = 100 - \\left(\\frac{15000}{29}\\right) \\cdot (0.104) = 100 - \\frac{15000 \\cdot 0.104}{29} = 100 - \\frac{1560}{29}$$\n$$P_{GC}' = \\frac{2900 - 1560}{29} = \\frac{1340}{29} \\text{ mmHg}$$\n\nNow, we calculate the new GFR, $GFR'$, using the constant $K_f$ and the new $P_{GC}'$:\n$$GFR' = K_f \\cdot (P_{GC}' - P_{BS} - \\pi_{GC})$$\n$$GFR' = \\left(\\frac{125}{12}\\right) \\cdot \\left(\\frac{1340}{29} - 15 - 25\\right) = \\left(\\frac{125}{12}\\right) \\cdot \\left(\\frac{1340}{29} - 40\\right)$$\n$$GFR' = \\left(\\frac{125}{12}\\right) \\cdot \\left(\\frac{1340 - 40 \\cdot 29}{29}\\right) = \\left(\\frac{125}{12}\\right) \\cdot \\left(\\frac{1340 - 1160}{29}\\right)$$\n$$GFR' = \\left(\\frac{125}{12}\\right) \\cdot \\left(\\frac{180}{29}\\right) = \\frac{125 \\cdot 180}{12 \\cdot 29} = \\frac{125 \\cdot 15}{29} = \\frac{1875}{29} \\text{ ml/min}$$\n\n**Part 3: Change in GFR**\n\nThe change in GFR, $\\Delta GFR$, is the difference between the new GFR and the baseline GFR:\n$$\\Delta GFR = GFR' - GFR_{base} = \\frac{1875}{29} - 125$$\n$$\\Delta GFR = \\frac{1875 - 125 \\cdot 29}{29} = \\frac{1875 - 3625}{29} = \\frac{-1750}{29} \\text{ ml/min}$$\n\nTo provide the final numerical answer, we compute the value of this fraction and round it to four significant figures:\n$$\\Delta GFR = \\frac{-1750}{29} \\approx -60.344827... \\text{ ml/min}$$\nRounding to four significant figures gives $-60.34$.", "answer": "$$\\boxed{-60.34}$$", "id": "4328593"}]}